×
返回 Agenda
Session 9: FDA: Focus on Enforcement
Session Chair(s)
Wayne Pines
President, Health Care, United States
This session will focus on FDA’s recent enforcement actions. Representatives from four FDA medical centers will dive deeply into specific recent enforcement actions, which will offer insights into the agency’s thought process on enforcement actions.
Learning Objective : At the conclusion of this session, participants should be able to: - Describe the latest ad promo enforcement actions from four FDA medical centers
- Identify FDA’s ad promo enforcement priorities
- Outline how FDA approaches ad promo enforcement actions
Speaker(s)
Thomas J. Moskal, DVM
Veterinary Medical Officer, FDA/CVM, United States
Panelist
Lisa Stockbridge, PHD
Branch Chief, Advertising and Promotional Labeling Branch, OCBQ, CBER, FDA, United States
Panelist
Deborah Wolf, JD
Regulatory Counsel, OPEQ , Regulatory Policy, CDRH, FDA, United States
Panelist
Thomas W. Abrams, MBA, RPH
Retired, Director, Office of Prescription Drug Promotion, OMP, CDER, Former FDA, United States
Panelist